Neffy, an intranasal formulation of epinephrine, is now available for emergency treatment of type I allergic reactions.
Harvard scientists developed a nasal spray, PCANS, which can trap and deactivate pathogens, showing promise in respiratory ...
Most respiratory viruses, like the flu and COVID-19, enter the body through the nose. When an infected person exhales, ...
Scientists have developed PCANS, a nasal spray that could potentially shield us from a wide range of airborne threats, from ...
FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.
A nasal spray to prevent influenza could make it easier for more people to get vaccinated, said Dr. Katherine Gergen-Barnett.
Whether it’s allergies, a sinus infection or runny nose, many people turn to nasal sprays for quick relief. Now, there’s ...
Nitin Joshi and Jeff Karp, coauthors and Harvard Medical School anesthesiology researchers, originally intended to create a ...
Supports Bentrio growth strategy together with strategic contract manufacturer and expanding network of international distributors ...
A new way to treat allergic reactions is coming to the market soon. Right now, many allergic reactions are treated with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback